Amerise Biosciences Ltd - Stock Valuation and Financial Performance

BSE: 531681 | NSE: | Finance - Investment | Small Cap

Amerise Biosciences Share Price

1.16 -0.06 -4.92%
as on 30-Dec'24 16:59

DeciZen - make an informed investing decision on Amerise Biosciences

M-Cap below 100cr DeciZen not available

Amerise Biosciences stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
8.1 Cr.
52-wk low:
0.6
52-wk high:
1.5

Is Amerise Biosciences Ltd an attractive stock to invest in?

1. Is Amerise Biosciences Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Amerise Biosciences Ltd is a below average quality company.

2. Is Amerise Biosciences Ltd undervalued or overvalued?

The key valuation ratios of Amerise Biosciences Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Amerise Biosciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Amerise Biosciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Amerise Biosciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Amerise Biosciences Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Operating Income (₹ Cr.)00001.2009000
YoY Gr. Rt. %-NANANANA-100%NANA-100%NA-
Adj EPS (₹ ) -00-0.100-0-0.10.1-0-0-0
YoY Gr. Rt. %-NANANANANANANA-125%NA-
BVPS (₹ )110.90.80.80.80.80.90.80.80.8
YoY Gr. Rt. %-0%-14.1%-1.2%0%-2.4%-6.1%10.4%-1.2%-3.6%-
To view Net Profit/Total Funds (%) Colour Rating Guide click here
Net Profit/Total Funds (%)-0.7-0.4-15.4-0.40.1-2.6-5.86.2-1.4-2.70

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Net Interest IncomeNA-100%NANA
Adj EPSNANANANA
BVPS-2.2%-0.7%1.7%-3.6%
Share Price -16.3% 6.2% -14.1% 65.7%

Key Financial Ratios

RATIOS \ YEARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Margins
Net Profit Margin (%)00000.4006.100-INF
Performance Ratios To view Performance Ratios Colour Rating Guide click here
Return on Equity (%)-0.7-0.4-15.5-0.40.1-2.7-6.410.2-2.1-2.7-2.4

Recent Performance Summary

No data to display

Return on Equity is Poor

Total Income has declined 0.00 CAGR in last 3 years

Net Profit has declined 0.00 CAGR in last 3 years

Total income growth is poor in last 4 quarters

Latest Financials - Amerise Biosciences Ltd.

Standalone Consolidated
TTM EPS (₹) -0 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 0.8 -
Reserves (₹ Cr.) -1 -
P/BV 1.52 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.55 / 1.45
All Time Low / High (₹) 0.54 / 30.00
Market Cap (₹ Cr.) 8.1
Equity (₹ Cr.) 6.6
Face Value (₹) 1
Industry PE 45.6

Management X-Ray of Amerise Biosciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Amerise Biosciences

Adj EPS (Rs.)

Total Income (Cr.)

ROE (%)

BVPS (Rs.)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Income00001.18009.580.010.04
Interest Income00001.18009.0100
Other Income 00000000.570.010.04
Expenditure 0.050.030.940.021.180.150.349.030.130.18
Interest Expense 0000000000
Operating Expenses 0.050.030.070.021.170.150.119.030.130.16
Provisions 000.870000.23000.02
Exceptional Items 0000000000
Profit Before Tax -0.05-0.03-0.94-0.020-0.15-0.340.55-0.12-0.15
Taxes 0000000000
Profit After Tax -0.05-0.03-0.94-0.020-0.15-0.340.55-0.12-0.15
Adjusted EPS (₹)0.00.0-0.10.00.00.0-0.10.10.00.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Equity Capital6.566.535.595.575.585.435.095.645.525.37
Share Capital 6.616.616.616.616.616.616.616.616.616.61
Reserves -0.05-0.07-1.01-1.03-1.03-1.18-1.52-0.97-1.09-1.23
Minority Interest0000000000
Long Term Borrowings00000000.080.090
Current Liabilities 00.010.050.020.020.600.546.270.040.02
Trade Payables000000.480.486.2700
Short term borrowings0000000000
Other Liabilities00000-0.48-0.48-6.2700
Total Liabilities 6.566.545.645.605.606.025.6311.995.655.39

Assets

Non Current Asset 2.876.482.912.881.1165.615.765.635.37
Loan Asset 0000000000
Other Non Current Asset 2.876.482.912.881.1165.615.765.635.37
Current Asset 3.690.062.732.724.490.030.026.230.010.02
Current Investment2.53000000000
Other Current Asset1.160.062.732.724.490.030.026.230.010.02
Total Assets 6.566.545.645.605.606.025.6311.995.655.39

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 0.271.08-3.56-0.04-1.784.89-0.390.06-0.13-0.17
Cash Flow From Investing Activity 0.32-1.073.550.031.77-4.890.39-0.150.130.27
Cash Flow From Financing Activity -0.590000000.080.01-0.09
Net Cash Flow 00-0.01-0.01-0.010.01-0.01-0.0100.01
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Operational & Financial Ratios

EPS (₹)0000000000
DPS (₹)0000000000
BVPS (₹)1111111111

Performance Ratios

ROA (%)-0.7-0.4-15.4-0.40.1-2.6-5.86.2-1.4-2.7
ROE (%)-0.7-0.4-15.5-0.40.1-2.7-6.410.2-2.1-2.7
ROCE (%)-0.7-0.4-15.5-0.40.1-2.7-6.410.2-2.1-2.7

Valuation Parameters

Price/Book(x)0.00.01.10.00.01.02.11.60.80.8

Amerise Biosciences Ltd Stock News

Amerise Biosciences Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Amerise Biosciences on 30-Dec-2024 16:59 is ₹1.16.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 30-Dec-2024 16:59 the market cap of Amerise Biosciences stood at ₹8.06.
The latest P/E ratio of Amerise Biosciences as of 30-Dec-2024 16:59 is 0.00.
The latest P/B ratio of Amerise Biosciences as of 30-Dec-2024 16:59 is 1.52.
The 52-week high of Amerise Biosciences is ₹1.45 and the 52-week low is ₹0.55.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Amerise Biosciences is ₹0.00 ( Cr.) .

About Amerise Biosciences Ltd

Amradeep Industries was incorporated in 1984, by a private Indian party, as a specialized manufacturer of high quality construction equipment and agricultural equipment. On October 29, 2002 the name of the company was changed from Amstar Laminates to Amardeep Industries.

The board of directors of the company on September 5, 2003, had proposed to sub divide the existing 66,06,900 equity shares of Rs 10 each in to share of Rs 1 each.

The registered office of the company is located at 24, Laxmi Chambers, Navjeevan Press Road, Opposite Old Gujarat High Court, Ahmedabad, Gujarat-380014.

Business area of the company

The company is engaged in commodity trading and in financial year (FY) 2007 it entered into the trading of castor seeds.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.